Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2020 Filed Mar 3, 2020 22:15 UTC |
Scoggins Christopher JSenior Vice President
|
SaleCommon shares without par value | 1,240 | $77.89 | $96,583.60 |
DisclosureSEC source: 0001179110-20-002894 · edgar.xml · nonDerivative · entry 2 Scoggins Christopher J · CIK 0001772286 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,168 Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:16 UTC |
Salvadori Daniel Gesua SiveExecutive Vice President
|
SaleCommon shares without par value | 999 | $77.89 | $77,812.11 |
DisclosureSEC source: 0001179110-20-002895 · edgar.xml · nonDerivative · entry 2 Salvadori Daniel Gesua Sive · CIK 0001620564 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,493 Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:16 UTC |
ALLEN HUBERT LExecutive Vice President
|
SaleCommon shares without par value | 1,208 | $77.89 | $94,091.12 |
DisclosureSEC source: 0001179110-20-002896 · edgar.xml · nonDerivative · entry 2 ALLEN HUBERT L · CIK 0001565916 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,896 Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:19 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 2,001 | $77.89 | $155,857.89 |
DisclosureSEC source: 0001179110-20-002897 · edgar.xml · nonDerivative · entry 2 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,019 Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:19 UTC |
Watkin JaredSenior Vice President
|
SaleCommon shares without par value | 1,761 | $77.89 | $137,164.29 |
DisclosureSEC source: 0001179110-20-002898 · edgar.xml · nonDerivative · entry 2 Watkin Jared · CIK 0001645118 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,944 Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:20 UTC |
Ginascol John FExecutive Vice President
|
SaleCommon shares without par value | 5,600 | $77.58 | $434,448.00 |
DisclosureSEC source: 0001179110-20-002899 · edgar.xml · nonDerivative · entry 3 Ginascol John F · CIK 0001778075 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,445 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.56 to $77.599, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:20 UTC |
Ginascol John FExecutive Vice President
|
SaleCommon shares without par value | 1,006 | $77.89 | $78,357.34 |
DisclosureSEC source: 0001179110-20-002899 · edgar.xml · nonDerivative · entry 2 Ginascol John F · CIK 0001778075 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,045 Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:21 UTC |
DALE MICHAEL DSenior Vice President
|
SaleCommon shares without par value | 787 | $77.89 | $61,299.43 |
DisclosureSEC source: 0001179110-20-002902 · edgar.xml · nonDerivative · entry 2 DALE MICHAEL D · CIK 0001172346 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,763 Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:23 UTC |
BIRD ROGERSenior Vice President
|
SaleCommon shares without par value | 666 | $77.89 | $51,874.74 |
DisclosureSEC source: 0001179110-20-002908 · edgar.xml · nonDerivative · entry 2 BIRD ROGER · CIK 0001635313 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,920 Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:27 UTC |
WOODGRIFT RANDEL WILLIAMSenior Vice President
|
SaleCommon shares without par value | 1,420 | $77.89 | $110,603.80 |
DisclosureSEC source: 0001179110-20-002918 · edgar.xml · nonDerivative · entry 2 WOODGRIFT RANDEL WILLIAM · CIK 0001204554 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,859 Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:28 UTC |
Funck, Jr. Robert E.Executive Vice President & CFO
|
SaleCommon shares without par value | 1,356 | $77.89 | $105,618.84 |
DisclosureSEC source: 0001179110-20-002920 · edgar.xml · nonDerivative · entry 2 Funck Robert E · CIK 0001565892 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,372 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:10 UTC |
Wainer Andrea FExecutive Vice President
|
Tax withholdingCommon shares without par value | 2,788 | $79.19 | $220,781.72 |
DisclosureSEC source: 0001179110-20-002891 · edgar.xml · nonDerivative · entry 1 Wainer Andrea F · CIK 0001778070 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,927 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:12 UTC |
YOOR BRIAN BExecutive Vice President & CFO
|
Tax withholdingCommon shares without par value | 14,318 | $79.19 | $1,133,842.42 |
DisclosureSEC source: 0001179110-20-002892 · edgar.xml · nonDerivative · entry 1 YOOR BRIAN B · CIK 0001643528 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,099 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:13 UTC |
BRYNELSEN CHARLESSenior Vice President
|
Tax withholdingCommon shares without par value | 4,720 | $79.19 | $373,776.80 |
DisclosureSEC source: 0001179110-20-002893 · edgar.xml · nonDerivative · entry 1 BRYNELSEN CHARLES · CIK 0001712459 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,241 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:15 UTC |
Scoggins Christopher JSenior Vice President
|
Tax withholdingCommon shares without par value | 2,420 | $79.19 | $191,639.80 |
DisclosureSEC source: 0001179110-20-002894 · edgar.xml · nonDerivative · entry 1 Scoggins Christopher J · CIK 0001772286 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,408 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:16 UTC |
Salvadori Daniel Gesua SiveExecutive Vice President
|
Tax withholdingCommon shares without par value | 12,279 | $79.19 | $972,374.01 |
DisclosureSEC source: 0001179110-20-002895 · edgar.xml · nonDerivative · entry 1 Salvadori Daniel Gesua Sive · CIK 0001620564 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,492 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:16 UTC |
ALLEN HUBERT LExecutive Vice President
|
Tax withholdingCommon shares without par value | 14,280 | $79.19 | $1,130,833.20 |
DisclosureSEC source: 0001179110-20-002896 · edgar.xml · nonDerivative · entry 1 ALLEN HUBERT L · CIK 0001565916 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,104 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:19 UTC |
Contreras JaimeSenior Vice President
|
Tax withholdingCommon shares without par value | 6,936 | $79.19 | $549,261.84 |
DisclosureSEC source: 0001179110-20-002897 · edgar.xml · nonDerivative · entry 1 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,020 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:19 UTC |
Watkin JaredSenior Vice President
|
Tax withholdingCommon shares without par value | 8,330 | $79.19 | $659,652.70 |
DisclosureSEC source: 0001179110-20-002898 · edgar.xml · nonDerivative · entry 1 Watkin Jared · CIK 0001645118 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,705 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:20 UTC |
Ginascol John FExecutive Vice President
|
Tax withholdingCommon shares without par value | 2,246 | $79.19 | $177,860.74 |
DisclosureSEC source: 0001179110-20-002899 · edgar.xml · nonDerivative · entry 1 Ginascol John F · CIK 0001778075 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,051 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:21 UTC |
DALE MICHAEL DSenior Vice President
|
Tax withholdingCommon shares without par value | 2,147 | $79.19 | $170,020.93 |
DisclosureSEC source: 0001179110-20-002902 · edgar.xml · nonDerivative · entry 1 DALE MICHAEL D · CIK 0001172346 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,550 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:22 UTC |
Wellisch Alejandro DSenior Vice President
|
Tax withholdingCommon shares without par value | 4,153 | $79.19 | $328,876.07 |
DisclosureSEC source: 0001179110-20-002904 · edgar.xml · nonDerivative · entry 2 Wellisch Alejandro D · CIK 0001717526 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,670 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:22 UTC |
Wellisch Alejandro DSenior Vice President
|
GrantCommon shares without par value | 11,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002904 · edgar.xml · nonDerivative · entry 1 Wellisch Alejandro D · CIK 0001717526 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,823 F1 · shares: Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:23 UTC |
BIRD ROGERSenior Vice President
|
Tax withholdingCommon shares without par value | 7,736 | $79.19 | $612,613.84 |
DisclosureSEC source: 0001179110-20-002908 · edgar.xml · nonDerivative · entry 1 BIRD ROGER · CIK 0001635313 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,586 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:25 UTC |
CAPEK JOHN MExecutive Vice President
|
Tax withholdingCommon shares without par value | 8,704 | $79.19 | $689,269.76 |
DisclosureSEC source: 0001179110-20-002915 · edgar.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,800 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:26 UTC |
PEDERSON MICHAEL JSenior Vice President
|
Tax withholdingCommon shares without par value | 4,176 | $79.19 | $330,697.44 |
DisclosureSEC source: 0001179110-20-002916 · edgar.xml · nonDerivative · entry 1 PEDERSON MICHAEL J · CIK 0001712233 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,891 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:26 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Tax withholdingCommon shares without par value | 46,827 | $79.19 | $3,708,230.13 |
DisclosureSEC source: 0001179110-20-002917 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,182,043 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:27 UTC |
WOODGRIFT RANDEL WILLIAMSenior Vice President
|
Tax withholdingCommon shares without par value | 3,533 | $79.19 | $279,778.27 |
DisclosureSEC source: 0001179110-20-002918 · edgar.xml · nonDerivative · entry 1 WOODGRIFT RANDEL WILLIAM · CIK 0001204554 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,279 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:28 UTC |
Ford Robert BPresident and COO
|
Tax withholdingCommon shares without par value | 16,638 | $79.19 | $1,317,563.22 |
DisclosureSEC source: 0001179110-20-002919 · edgar.xml · nonDerivative · entry 1 Ford Robert B · CIK 0001612571 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,543 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:28 UTC |
Funck, Jr. Robert E.Executive Vice President & CFO
|
Tax withholdingCommon shares without par value | 6,710 | $79.19 | $531,364.90 |
DisclosureSEC source: 0001179110-20-002920 · edgar.xml · nonDerivative · entry 1 Funck Robert E · CIK 0001565892 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,728 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:30 UTC |
MANNING JOSEPH JSenior Vice President
|
Tax withholdingCommon shares without par value | 5,909 | $79.19 | $467,933.71 |
DisclosureSEC source: 0001179110-20-002923 · edgar.xml · nonDerivative · entry 2 MANNING JOSEPH J · CIK 0001695686 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,811 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:30 UTC |
MANNING JOSEPH JSenior Vice President
|
GrantCommon shares without par value | 4,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002923 · edgar.xml · nonDerivative · entry 1 MANNING JOSEPH J · CIK 0001695686 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,720 F1 · shares: Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:30 UTC |
LANE ANDREW HExecutive Vice President
|
Tax withholdingCommon shares without par value | 5,243 | $79.19 | $415,193.17 |
DisclosureSEC source: 0001179110-20-002924 · edgar.xml · nonDerivative · entry 2 LANE ANDREW H · CIK 0001643735 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,523 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:30 UTC |
LANE ANDREW HExecutive Vice President
|
GrantCommon shares without par value | 23,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002924 · edgar.xml · nonDerivative · entry 1 LANE ANDREW H · CIK 0001643735 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,766 F1 · shares: Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:31 UTC |
Karam SammySenior Vice President
|
Tax withholdingCommon shares without par value | 1,972 | $79.19 | $156,162.68 |
DisclosureSEC source: 0001179110-20-002925 · edgar.xml · nonDerivative · entry 2 Karam Sammy · CIK 0001766718 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,921 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:31 UTC |
Karam SammySenior Vice President
|
GrantCommon shares without par value | 5,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002925 · edgar.xml · nonDerivative · entry 1 Karam Sammy · CIK 0001766718 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,893 F1 · shares: Settlement of performance-based restricted stock units in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 25, 2020 Filed Feb 25, 2020 22:29 UTC |
Moreland Mary KExecutive Vice President
|
SaleCommon shares without par value | 400 | $84.93 | $33,972.00 |
DisclosureSEC source: 0001179110-20-002281 · edgar.xml · nonDerivative · entry 3 Moreland Mary K · CIK 0001783147 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,131 Read SEC document |
| February 22, 2020 Filed Feb 25, 2020 22:29 UTC |
Moreland Mary KExecutive Vice President
|
Tax withholdingCommon shares without par value | 780 | $87.45 | $68,211.00 |
DisclosureSEC source: 0001179110-20-002281 · edgar.xml · nonDerivative · entry 2 Moreland Mary K · CIK 0001783147 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,531 Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:10 UTC |
Scoggins Christopher JSenior Vice President
|
GrantOption (right to buy) · Derivative | 68,578 | $0.00 Strike: $87.72 | $0.00 |
DisclosureSEC source: 0001179110-20-002261 · edgar.xml · derivative · entry 2 Scoggins Christopher J · CIK 0001772286 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,578 Underlying: Common shares · 68,578 shares Expires 2030-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 22,859 on February 21, 2021, 22,859 on February 21, 2022, and 22,860 on February 21, 2023. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:10 UTC |
Scoggins Christopher JSenior Vice President
|
GrantCommon shares without par value | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002261 · edgar.xml · nonDerivative · entry 1 Scoggins Christopher J · CIK 0001772286 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,828 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:12 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 416,956 | $0.00 Strike: $87.72 | $0.00 |
DisclosureSEC source: 0001179110-20-002262 · edgar.xml · derivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,956 Underlying: Common shares · 416,956 shares Expires 2030-02-20 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 138,985 on February 21, 2021, 138,985 on February 21, 2022, and 138,986 on February 21, 2023. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:12 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantCommon shares without par value | 68,399 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002262 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,228,870 F1 · shares: These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:13 UTC |
BIRD ROGERSenior Vice President
|
GrantOption (right to buy) · Derivative | 87,628 | $0.00 Strike: $87.72 | $0.00 |
DisclosureSEC source: 0001179110-20-002263 · edgar.xml · derivative · entry 2 BIRD ROGER · CIK 0001635313 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,628 Underlying: Common shares · 87,628 shares Expires 2030-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 29,209 on February 21, 2021, 29,209 on February 21, 2022, and 29,210 on February 21, 2023. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:13 UTC |
BIRD ROGERSenior Vice President
|
GrantCommon shares without par value | 14,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002263 · edgar.xml · nonDerivative · entry 1 BIRD ROGER · CIK 0001635313 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,322 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:14 UTC |
Funck, Jr. Robert E.Senior Vice President
|
GrantOption (right to buy) · Derivative | 154,013 | $0.00 Strike: $87.72 | $0.00 |
DisclosureSEC source: 0001179110-20-002264 · edgar.xml · derivative · entry 5 Funck Robert E · CIK 0001565892 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,013 Underlying: Common shares · 154,013 shares Expires 2030-02-20 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 51,337 on February 21, 2021, 51,338 on February 21, 2022, and 51,338 on February 21, 2023. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:14 UTC |
Funck, Jr. Robert E.Senior Vice President
|
GrantCommon shares without par value | 25,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002264 · edgar.xml · nonDerivative · entry 1 Funck Robert E · CIK 0001565892 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,438 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:18 UTC |
Ginascol John FExecutive Vice President
|
GrantOption (right to buy) · Derivative | 114,940 | $0.00 Strike: $87.72 | $0.00 |
DisclosureSEC source: 0001179110-20-002268 · edgar.xml · derivative · entry 2 Ginascol John F · CIK 0001778075 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,940 Underlying: Common shares · 114,940 shares Expires 2030-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 38,313 on February 21, 2021, 38,313 on February 21, 2022, and 38,314 on February 21, 2023. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:18 UTC |
Ginascol John FExecutive Vice President
|
GrantCommon shares without par value | 18,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002268 · edgar.xml · nonDerivative · entry 1 Ginascol John F · CIK 0001778075 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,297 F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:19 UTC |
YOOR BRIAN BExecutive Vice President & CFO
|
GrantOption (right to buy) · Derivative | 85,562 | $0.00 Strike: $87.72 | $0.00 |
DisclosureSEC source: 0001179110-20-002269 · edgar.xml · derivative · entry 3 YOOR BRIAN B · CIK 0001643528 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,562 Underlying: Common shares · 85,562 shares Expires 2030-02-20 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 28,520 on February 21, 2021, 28,521 on February 21, 2022, and 28,521 on February 21, 2023. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 22:19 UTC |
YOOR BRIAN BExecutive Vice President & CFO
|
GrantCommon shares without par value | 14,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-002269 · edgar.xml · nonDerivative · entry 1 YOOR BRIAN B · CIK 0001643528 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,417 F1 · shares: These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.